XML 64 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt
9 Months Ended
Sep. 30, 2014
Long-Term Debt [Abstract]  
Long-Term Debt

5.   Long-Term Debt

 

On May 15, 2014, we retired our Senior Convertible Notes (the “Notes”) outstanding.  We paid the $187.0 million of principal outstanding using a combination of cash on-hand and our existing revolving credit facility.  In addition, we issued 249,000 Chemed shares in conjunction with the conversion feature of the Notes.  At the time we issued the Notes, we also entered into a purchased call transaction to offset any potential economic dilution resulting from the conversion feature in the Notes.  As a result, we received 266,000 Chemed shares from the exercise of the purchased call transaction.  The issuance of shares under the conversion feature of the Notes, as well as the receipt of shares from the purchased call transaction were recorded as adjustments to paid-in capital during the quarter ended June 30, 2014.

 

On June 30, 2014, we replaced our existing credit agreement with the Third Amended and Restated Credit Agreement (“2014 Credit Agreement”).  Terms of the 2014 Credit Agreement consist of a five-year, $350 million revolving credit facility and a $100 million term loan.  The 2014 Credit Agreement has a floating interest rate that is currently LIBOR plus 113 basis points. 

 

The debt outstanding consists of the following:

 

 

 

 

 

 

 

Revolver

$

74,800,000 

Term loan

 

98,750,000 

Total

 

173,550,000 

Current portion of term and revolving loan

 

(20,425,000)

Long-term debt

$

153,125,000 

Scheduled principal payments of the term loan are as follows:

 

 

 

 

2014 

$

1,250,000 
2015 

 

6,250,000 
2016 

 

7,500,000 
2017 

 

8,750,000 
2018 

 

10,000,000 
2019 

 

65,000,000 

 

$

98,750,000 

 

Debt issuance costs associated with the existing credit agreement were not written-off as the lenders and their relative percentage participation in the facility did not change. With respect to the 2014 Credit Agreement, deferred financing costs were $0.9 million.  The 2014 Credit Agreement contains the following quarterly financial covenants: 

 

 

 

 

 

 

 

 

Description

 

Requirement

 

 

 

Leverage Ratio (Consolidated Indebtedness/Consolidated  Adj. EBITDA)

 

<  3.50 to 1.00

 

 

 

Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges)

 

>  1.50 to 1.00

 

 

 

Annual Operating Lease Commitment

 

<  $50.0 million

 

We are in compliance with all debt covenants as of September 30, 2014. We have issued $36.9 million in standby letters of credit as of September 30, 2014 for insurance purposes.  Issued letters of credit reduce our available credit under the 2014 Credit Agreement.  As of September 30, 2014, we have approximately $238.3 million of unused lines of credit available and eligible to be drawn down under our revolving credit facility.